跳至主要内容
临床试验/NCT04519346
NCT04519346已完成不适用

Comparison of Intradermal Mesotherapy With Systemic Therapy in the Treatment of Migraine Headache: A Prospective Randomized Study

Ataturk University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
change in headache intensity

研究概览

简要总结

Introduction:Migraine is a prevalent disabling primary headache disorder which is classified in two major types; migraine without aura and migraine with aura. The aim of this study was to compare the efficiency of mesotherapy with systemic therapy in pain controlin patients with headache related tomigraine without aura.

Methods: We conducted this prospective parallel randomized controlled trial with the patients admitted to the emergency department with headache related to migraine without aura. One group was treated with mesotherapy, and the control group with intravenous dexketoprofen. Changes in pain intensity at 30th minute, 60th minute, 120th minute and 24th hours after treatment using Visual Analogue Scale (VAS), need to use analgesic drug within 24 hours,re-admission with same complaint to emergency department (ED) within 72 hours, and adverse effect rate of the methods were compared between groups.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older age, and (2)
  • Admission to Emergency Department (ED) with headache related to the migraine without aura.

排除标准

  • Taking analgesic drugs before admission,
  • Having VAS score of lower than 4 on admission,
  • Having diabetes mellitus,
  • Body mass index>30 kg/m2,
  • Pregnancy,
  • Lactation,
  • Having active bleeding or bleeding disorder,
  • Having active or recurrent gastrointestinal hemorrhage or ulcer, or history of these conditions,
  • Having a serious or life-threatening condition (stroke, intracranial hemorrhage, heart attack, cardiac tamponade, pneumothorax, hemothorax, flail chest, etc.).

结局指标

主要结局

change in headache intensity

时间窗: 0-24 hours

Visual Analog Score(points between 0-10. the most severe pain 10 points, no pain 0 points) scores at 30th, 60th and 120th minutes, and 24th hours from the baseline VAS score (at the beginning of the treatment).

need to use analgesics within 24 hours after treatment

时间窗: 0-24 hours

We defined this as a requirement of any type analgesics for painkilling at any time within 24 hours of treatment, and this was evaluated by patients, subjectively. we will learn by asking by phone.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdullah Osman KOCAK

Principal Investigator

Ataturk University

研究点 (1)

Loading locations...

相似试验